Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.67 USD | +0.42% | +5.22% | -43.28% |
05-14 | Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression | MT |
05-14 | Neumora Therapeutics, Inc. Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression | CI |
- Stock Market
- Equities
- NMRA Stock
- News Neumora Therapeutics, Inc.
- Other languages